Narayan Prabhu

2021

In 2021, Narayan Prabhu earned a total compensation of $437.1K as Chief Financial Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 865% increase compared to previous year.

Compensation breakdown

Option Awards$162,134
Salary$275,000
Total$437,134

Prabhu received $275K in salary, accounting for 63% of the total pay in 2021.

Prabhu also received $162.1K in option awards.

Rankings

In 2021, Narayan Prabhu's compensation ranked 11,004th out of 12,415 executives tracked by ExecPay. In other words, Prabhu earned more than 11.4% of executives.

ClassificationRankingPercentile
All
11,004
out of 12,415
11th
Division
Manufacturing
4,855
out of 5,505
12th
Major group
Chemicals And Allied Products
2,169
out of 2,375
9th
Industry group
Drugs
1,930
out of 2,096
8th
Industry
Pharmaceutical Preparations
1,429
out of 1,546
8th
Source: SEC filing on October 11, 2022.

Prabhu's colleagues

We found two more compensation records of executives who worked with Narayan Prabhu at REVIVA PHARMACEUTICALS HOLDINGS in 2021.

2021

Laxminarayan Bhat

REVIVA PHARMACEUTICALS HOLDINGS

Chief Executive Officer

2021

Marc Cantillon

REVIVA PHARMACEUTICALS HOLDINGS

Chief Medical Officer

News

You may also like